Immunome president and CEO Clay Siegall disclosed the purchase of 169,204 common shares of the company on October 2 at a price of $5.91 per share.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>